Full name
CHARLES RIVER LABORATORIES POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
70.22.Z - Business and other management consultancy activities
71.12.Z - Engineering activities and related technical consultancy
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
82.99.Z - Other business support service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | 0,9 | 0,1 | -83,7 |
EBITDA | 0,3 | 0,9 | 0,2 | -83,6 |
Short time liabilities | 0 | 0,1 | 0,1 | -23 |
Equity capital | 0,6 | 1,5 | 1,6 | 8,4 |
Operating profit (EBIT) | 0,3 | 0,9 | 0,2 | -83,6 |
Assets | 0,8 | 1,8 | 1,9 | 4,7 |
Net profit (loss) | 0,3 | 0,8 | 0,1 | -85,1 |
Cash | 0,3 | 1,2 | 1,4 | 15,8 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,3 | -11,9 |
Net income from sale | 1,2 | 2,4 | 1,8 | -24,5 |
Working assets | 0,8 | 1,8 | 1,9 | 4,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 42,3 | 56,1 | 7,7 | -48,4 |
Equity capital to total assets | 79,9 | 81,8 | 84,6 | 2,8 |
Gross profit margin | 25,5 | 38,1 | 8,2 | -29,9 |
EBITDA Margin | 25,6 | 38,3 | 8,3 | -30 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 7 | 14 | 14 | 0 |
Current financial liquidity indicator | 4.946249961853027 | 5.4626874923706055 | 6.4919633865356445 | 1 |
Net dept to EBITDA | -1.1529656648635864 | -1.302807092666626 | -9.204028129577637 | -7,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane